<DOC>
	<DOCNO>NCT01342211</DOCNO>
	<brief_summary>This study investigate effect PF-04950615 , new investigational lipid lower agent , LDL-C lipid .</brief_summary>
	<brief_title>A Multiple Dose Study PF-04950615 ( RN316 ) Subjects High Doses Statins</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>On stable daily dose atorvastatin , rosuvastatin simvastatin . Lipids meet follow criterion screen prior dosing : Fasting LDLC great 100 mg/dL fast TG le 400 mg/dL History cardiovascular cerebrovascular event procedure past year . Poorly control type 1 type 2 diabetes mellitus . Poorly control hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>PF-04950615</keyword>
	<keyword>RN316</keyword>
</DOC>